Metoject® PEN

Metoject® PEN Administration Guide

Metoject® PEN adult administration guidelines

Metoject® PEN child administration guidelines

About Metoject® PEN

Metoject® PEN is a licensed, single use, 50mg/ml pre-filled single use device for subcutaneous methotrexate injection.

Therapeutic Indications1

Metoject® PEN is indicated for the treatment of:

  • Active rheumatoid arthritis in adult patients
  • Polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate
  • Moderate to severe psoriasis in adult patients who are candidates for systemic therapy, and severe psoriatic arthritis in adults
  • Mild to moderate Crohn’s disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines

1. Metoject® Summary of Product Characteristics (SmPC)

Metoject® PEN SPC

Metoject® PEN SPC

Metoject® PEN Prescribing Information

Metoject® PEN abbreviated prescribing information

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to medac drug safety at:

Contact us

For further information on Metoject® PEN, please contact:

medac Pharma
T: 01786 458086